Please login to the form below

Not currently logged in
Email:
Password:

Biogen

This page shows the latest Biogen news and features for those working in and with pharma, biotech and healthcare.

After mixed signals, will Eisai and Biogen press on with Alzheimer’s hopeful?

After mixed signals, will Eisai and Biogen press on with Alzheimer’s hopeful?

After mixed signals, will Eisai and Biogen press on with Alzheimer’ s hopeful? ... Eisai and Biogen have yet to confirm if they will proceed into phase 3 trials, though this still looks likely.

Latest news

More from news
Approximately 97 fully matching, plus 277 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    to 12-week course. And Spinraza from Biogen, the first ever disease-modifying treatment for spinal muscular atrophy (SMA), which increases the body’s ability to produce SMN protein critical to.

  • Deal Watch January 2018

    Biogen's spin-out, Bioverativ, had not even got past its first anniversary as a Nasdaq-listed company before being snapped up by Sanofi for $11.6bn (although this is not ... Option, licence. 223. Karyopharm Therapeutics/ Biogen. Oral SINE compound

  • The good, the bad and the ugly The good, the bad and the ugly

    Biogen was the largest seller in the CNS market in 2017 and this is forecast to continue, ”says Rahael Maladwala, analyst, neurology and ophthalmology, GlobalData. ... Biogen also has Aducanumab in the pipeline, which is forecast to generate huge sales

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    Biogen, one of Align Biopharma’s founding members. ... Other founding members include Allergan, AstraZeneca, Biogen, GlaxoSmithKline, Novartis and Pfizer.

  • Managing medication non-adherence Managing medication non-adherence

    efficacious. Biogen has been playing in this space for a few years now and conducted a clinical trial with PatientsLikeMe that showed how people living with multiple sclerosis (MS) can use

More from intelligence
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest appointments

More from appointments
Approximately 16 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...

Infographics